SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter A. DeMaria, Cocaine Use and Buprenorphine Compliance, Journal of Addiction Medicine, 2015, 9, 3, 251

    CrossRef

  2. 2
    Sandra A. Springer, Frederick L. Altice, Shan-Estelle Brown, Angela Di Paola, Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system, Drug and Alcohol Dependence, 2015, 157, 158

    CrossRef

  3. 3
    Pierpaolo Congia, Maria Germana Orrù, Mercedes Masia, Elisabetta Muscas, Sebastiana Manca, Predicting Outcome in Public Addiction Services Using Data Collected During Routinely Assessment Procedures, International Journal of Mental Health and Addiction, 2015,

    CrossRef

  4. 4
    Jeanette M. Tetrault, Elinore F. McCance-Katz, David E. Moody, David A. Fiellin, Bonnie S. Lruie, An T. DInh, Lynn E. Fiellin, The Impact of Recent Cocaine Use on Plasma Levels of Methadone and Buprenorphine in Patients with and Without HIV-infection, Journal of Substance Abuse Treatment, 2015, 51, 70

    CrossRef

  5. 5
    Xiaofan Li, Daryl Shorter, Thomas R Kosten, Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies, Expert Opinion on Pharmacotherapy, 2014, 15, 15, 2263

    CrossRef

  6. 6
    Zev Schuman-Olivier, Roger D. Weiss, Bettina B. Hoeppner, Jacob Borodovsky, Mark J. Albanese, Emerging adult age status predicts poor buprenorphine treatment retention, Journal of Substance Abuse Treatment, 2014, 47, 3, 202

    CrossRef

  7. 7
    Anne M. Neumann, Richard D. Blondell, Urmo Jaanimägi, Amanda K. Giambrone, Gregory G. Homish, Jacqueline R. Lozano, Urszula Kowalik, Mohammadreza Azadfard, A Preliminary Study Comparing Methadone and Buprenorphine in Patients with Chronic Pain and Coexistent Opioid Addiction, Journal of Addictive Diseases, 2013, 32, 1, 68

    CrossRef

  8. 8
    Jeanette M. Tetrault, Michael J. Kozal, Jennifer Chiarella, Lynn E. Sullivan, An T. Dinh, David A. Fiellin, Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment, Journal of Addiction Medicine, 2013, 7, 2, 102

    CrossRef

  9. 9
    Chinazo O. Cunningham, Angela Giovanniello, Hillary V. Kunins, Robert J. Roose, Aaron D. Fox, Nancy L. Sohler, Buprenorphine Treatment Outcomes among Opioid-Dependent Cocaine Users and Non-Users, The American Journal on Addictions, 2013, 22, 4
  10. 10
    E. Jennifer Edelman, Brent A. Moore, Sarah Caffrey, Kathleen J. Sikkema, Emlyn S. Jones, Richard S. Schottenfeld, David A. Fiellin, Lynn E. Fiellin, HIV Testing and Sexual Risk Reduction Counseling in Office-Based Buprenorphine/Naloxone Treatment, Journal of Addiction Medicine, 2013, 7, 6, 410

    CrossRef

  11. 11
    Lindsay Weiss, Nancy M. Petry, Older Methadone Patients Achieve Greater Durations of Cocaine Abstinence with Contingency Management Than Younger Patients, The American Journal on Addictions, 2013, 22, 2
  12. 12
    Jessica A. Dreifuss, Margaret L. Griffin, Katherine Frost, Garrett M. Fitzmaurice, Jennifer Sharpe Potter, David A. Fiellin, Jeffrey Selzer, Mary Hatch-Maillette, Susan C. Sonne, Roger D. Weiss, Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study, Drug and Alcohol Dependence, 2013, 131, 1-2, 112

    CrossRef

  13. 13
    Élise Roy, Isabelle Richer, Nelson Arruda, Jill Vandermeerschen, Julie Bruneau, Patterns of cocaine and opioid co-use and polyroutes of administration among street-based cocaine users in Montréal, Canada, International Journal of Drug Policy, 2013, 24, 2, 142

    CrossRef

  14. 14
    Jonathan D. Savant, Declan T. Barry, Christopher J. Cutter, Michelle T. Joy, An Dinh, Richard S. Schottenfeld, David A. Fiellin, Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment, Drug and Alcohol Dependence, 2013, 127, 1-3, 243

    CrossRef

  15. 15
    Anne M. Neumann, Richard D. Blondell, Mohammadreza Azadfard, Ganon Nathan, Gregory G. Homish, Primary care patient characteristics associated with completion of 6-month buprenorphine treatment, Addictive Behaviors, 2013, 38, 11, 2724

    CrossRef

  16. 16
    Jan Gryczynski, Shannon Gwin Mitchell, Jerome H. Jaffe, Sharon M. Kelly, C. Patrick Myers, Kevin E. O'Grady, Yngvild K. Olsen, Robert P. Schwartz, Retention in methadone and buprenorphine treatment among African Americans, Journal of Substance Abuse Treatment, 2013, 45, 3, 287

    CrossRef

  17. 17
    Brent A. Moore, Tera Fazzino, Declan T. Barry, David A. Fiellin, Christopher J. Cutter, Richard S. Schottenfeld, Samuel A. Ball, The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance, Journal of Substance Abuse Treatment, 2013, 45, 1, 63

    CrossRef

  18. 18
    Helena B. Hansen, Carole E. Siegel, Brady G. Case, David N. Bertollo, Danae DiRocco, Marc Galanter, Variation in Use of Buprenorphine and Methadone Treatment by Racial, Ethnic, and Income Characteristics of Residential Social Areas in New York City, The Journal of Behavioral Health Services & Research, 2013, 40, 3, 367

    CrossRef

  19. 19
    Jeanette M. Tetrault, Brent A. Moore, Declan T. Barry, Patrick G. O'Connor, Richard Schottenfeld, David A. Fiellin, Lynn E. Fiellin, Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients, Journal of Substance Abuse Treatment, 2012, 43, 4, 433

    CrossRef

  20. 20
    Ryan Schwarz, Alexei Zelenev, R. Douglas Bruce, Frederick L. Altice, Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence, Journal of Substance Abuse Treatment, 2012, 43, 4, 451

    CrossRef

  21. 21
    Jeffrey D. Baxter, Robin E. Clark, Mihail Samnaliev, Gary Y. Leung, Lobat Hashemi, Factors associated with Medicaid patients' access to buprenorphine treatment, Journal of Substance Abuse Treatment, 2011, 41, 1, 88

    CrossRef

  22. 22
    Lynn E Sullivan, Michael Botsko, Chinazo O Cunningham, Patrick G OʼConnor, David Hersh, Jennifer Mitty, Paula J Lum, Richard S Schottenfeld, David A Fiellin, The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/Naloxone, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2011, 56, S54

    CrossRef

  23. 23
    Kevin A. Sevarino, Bryan C. Shelby, Stimulant Use Disorders,